BioCryst Pharmaceuticals, Inc. (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

7.91

-0.16 (-1.98%)

At close: Sep 12, 2025, 4:00 PM EDT

7.90

-0.01 (-0.13%)

After-hours: Sep 12, 2025, 7:16 PM EDT

BioCryst Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	557.51	450.71	331.41	270.83	157.17	17.81	Upgrade
Revenue Growth (YoY)	45.85%	36.00%	22.37%	72.31%	782.38%	-63.53%	Upgrade
Cost of Revenue	186.86	185.92	216.65	259.89	216.07	124.64	Upgrade
Gross Profit	370.64	264.79	114.76	10.94	-58.9	-106.83	Upgrade
Selling, General & Admin	315.18	266.07	213.54	159.37	118.82	62.9	Upgrade
Operating Expenses	315.18	266.07	213.54	159.37	118.82	62.9	Upgrade
Operating Income	55.46	-1.28	-98.78	-148.44	-177.72	-169.73	Upgrade
Interest Expense	-94.35	-98.52	-108.24	-99.09	-59.29	-14.5	Upgrade
Interest & Investment Income	12.7	14.75	15.78	5.13	0.06	0.53	Upgrade
Currency Exchange Gain (Loss)	-0.57	-0.64	-1.04	-1.98	-0.7	-0.97	Upgrade
EBT Excluding Unusual Items	-26.76	-85.69	-192.28	-244.38	-237.65	-184.67	Upgrade
Merger & Restructuring Charges	-1.26	-1.26	-3.38	-	-	-	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	0	-	Upgrade
Asset Writedown	-	-	-1.55	-	-	-	Upgrade
Legal Settlements	-	-	-	-	-	3.87	Upgrade
Other Unusual Items	-4.17	-	-29.02	-	55.84	-2.01	Upgrade
Pretax Income	-32.19	-86.95	-226.23	-244.38	-181.81	-182.81	Upgrade
Income Tax Expense	3.52	1.93	0.31	2.73	2.25	-	Upgrade
Net Income	-35.71	-88.88	-226.54	-247.12	-184.06	-182.81	Upgrade
Net Income to Common	-35.71	-88.88	-226.54	-247.12	-184.06	-182.81	Upgrade
Shares Outstanding (Basic)	208	207	192	186	179	167	Upgrade
Shares Outstanding (Diluted)	208	207	192	186	179	167	Upgrade
Shares Change (YoY)	3.62%	7.54%	3.38%	3.79%	7.08%	44.70%	Upgrade
EPS (Basic)	-0.17	-0.43	-1.18	-1.33	-1.03	-1.09	Upgrade
EPS (Diluted)	-0.18	-0.43	-1.18	-1.33	-1.03	-1.09	Upgrade
Free Cash Flow	15.76	-53.14	-97.31	-163.2	-144.54	-135.62	Upgrade
Free Cash Flow Per Share	0.08	-0.26	-0.51	-0.88	-0.81	-0.81	Upgrade
Gross Margin	66.48%	58.75%	34.63%	4.04%	-37.48%	-	Upgrade
Operating Margin	9.95%	-0.28%	-29.81%	-54.81%	-113.07%	-952.90%	Upgrade
Profit Margin	-6.40%	-19.72%	-68.36%	-91.25%	-117.11%	-1026.35%	Upgrade
Free Cash Flow Margin	2.83%	-11.79%	-29.36%	-60.26%	-91.97%	-761.41%	Upgrade
EBITDA	58.51	1.73	-95.91	-146.18	-176.83	-168.98	Upgrade
EBITDA Margin	10.49%	0.39%	-28.94%	-53.98%	-112.51%	-	Upgrade
D&A For EBITDA	3.05	3.01	2.87	2.25	0.89	0.75	Upgrade
EBIT	55.46	-1.28	-98.78	-148.44	-177.72	-169.73	Upgrade
EBIT Margin	9.95%	-0.28%	-29.81%	-54.81%	-113.07%	-	Upgrade
Revenue as Reported	-	-	-	-	-	17.81	Upgrade
Advertising Expenses	-	13.57	14.4	14.89	5.71	6.57	Upgrade

Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q